|
Volumn 458, Issue 2, 2007, Pages 202-212
|
Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase
|
Author keywords
DNA polymerase; HIV 1; Inhibition; Integrase; Modeling; Peptides; Reverse transcriptase
|
Indexed keywords
ALANYLGLUTAMYLVALYLISOLEUCYLPROLYLALANYLGLUTAMYLTHREONYLGLYCYL GLUTAMINYLGLUTAMYLTHREONYLALANYLTYROSYLPHENYLALANYLLEUCYLLEUCYLLYSYLLEUCYL ALANINE;
ALANYLGLYCYLGLUTAMYLARGINYLISOLEUCYLVALYLASPARTYLISOLEUCYL ISOLEUCYLALANYLTHREONYLASPARTYLISOLEUCYLGLUTAMINYLTHREONYLLYSYL GLUTAMYLLEUCYLGLUTAMINYLLYSINE;
ALANYLVALYLHISTIDYLVALYLALANYLSERYLGLYCYLTYROSYLISOLEUCYL GLUTAMYLALANYLGLUTAMYLVALYLISOLEUCYLPROLYLALANYLGLUTAMYLTHREONYLGLYCYLGLUTAMINE;
ARGINYLASPARTYLGLUTAMINYLALANYLGLUTAMYLHISTIDYLLEUCYLLYSYL THREONYLALANYLVALYLGLUTAMINYLMETHIONYLALANYLVALYLPHENYLALANYLISOLEUCYL HISTIDYLASPARAGINYLPHENYLALANINE;
ASPARTYLASPARAGINYLGLYCYLSERYLASPARAGINYLPHENYLALANYL THREONYLGLYCYLALANYLTHREONYLVALYLARGINYLALANYLALANYLCYSTEINYLTRYPTOPHANYL TRYPTOPHANYLALANYLGLYCYLISOLEUCINE;
ASPARTYLLYSYLALANYLGLUTAMINYLASPARTYLGLUTAMYLHISTIDYL GLUTAMYLLYSYLTYROSYLHISTIDYLSERYLASPARAGINYLTRYPTOPHANYLARGINYLALANYL METHIONYLALANYLSERYLASPARTIC ACID;
CYSTEINYLSERYLPROLYLGLYCYLISOLEUCYLTRYPTOPHANYL GLUTAMINYLLEUCYLASPARTYLCYSTEINYLTHREONYLHISTIDYLLEUCYL GLUTAMYLGLYCYLLYSYLVALYLISOLEUCYLLEUCYLVALINE;
DNA POLYMERASE;
GLUTAMINYLISOLEUCYLTHREONYLLYSYLISOLEUCYLGLUTAMINYL ASPARAGINYLPHENYLALANYLARGINYLVALYLTYROSYLTYROSYLARGINYLASPARTYLSERYL ARGINYLASPARAGINYLPROLYLLEUCYLTRYPTOPHAN;
GLUTAMINYLSERYLGLUTAMINYLGLYCYLVALYLVALYLGLUTAMYLSERYL METHIONYLASPARAGINYLLYSYLGLUTAMYLLEUCYLLYSYLLYSYLISOLEUCYLISOLEUCYLGLYCYL GLUTAMINYLVALINE;
GLUTAMYLTHREONYLALANYLTYROSYLPHENYLALANYLLEUCYLLEUCYLLYSYLLEUCYL ALANYLGLYCYLARGINYLTRYPTOPHANYLPROLYLVALYLLYSYLTHREONYLISOLEUCYL HISTIDYLTHREONINE;
GLYCYLARGINYLTRYPTOPHANYLPROLYLVALYLLYSYLTHREONYLISOLEUCYL HISTIDYLTHREONYLASPARTYLASPARAGINYLGLYCYLSERYLASPARAGINYLPHENYLALANYL THREONYLGLYCYLALANYLTHREONINE;
HISTIDYLSERYLASPARAGINYLTRYPTOPHANYLARGINYLALANYL METHIONYLALANYLSERYLASPARTYLPHENYLALANYLASPARAGINYLLEUCYL PROLYLPROLYLVALYLVALYLALANYLLYSYLGLUTAMIC ACID;
INTEGRASE;
ISOLEUCYLARGINYLLYSYLVALYLLEUCYLPHENYLALANYLLEUCYLASPARTYL GLYCYLISOLEUCYLASPARTYLLYSYLALANYLGLUTAMINYLASPARTYLGLUTAMYLHISTIDYL GLUTAMYLLYSYLTYROSINE;
ISOLEUCYLVALYLALANYLSERYLCYSTEINYLASPARTYLLYSYLCYSTEINYL GLUTAMINYLLEUCYLLYSYLGLYCYLGLUTAMYLALANYLMETHIONYLHISTIDYLGLYCYL GLUTAMINYLVALYLASPARTIC ACID;
LYSYLARGINYLLYSYLGLYCYLGLYCYLISOLEUCYLGLYCYLGLYCYLTYROSYLSERYL ALANYLGLYCYLGLUTAMYLARGINYLISOLEUCYLVALYLASPARTYLISOLEUCYLISOLEUCYLALANINE;
LYSYLGLUTAMINYLGLUTAMYLPHENYLALANYLGLYCYLISOLEUCYLPROLYLTYROSYL ASPARAGINYLPROLYLGLUTAMINYLSERYLGLUTAMINYLGLYCYLVALYLVALYLGLUTAMYLSERYL METHIONYLASPARAGINE;
LYSYLGLUTAMYLLEUCYLLYSYLLYSYLISOLEUCYLISOLEUCYLGLYCYL GLUTAMINYLVALYLARGINYLASPARTYLGLUTAMINYLALANYLGLUTAMYL HISTIDYLLEUCYLLYSYLTHREONYLALANINE;
LYSYLGLYCYLGLUTAMYLALANYLMETHIONYLHISTIDYLGLYCYL GLUTAMINYLVALYLASPARTYLCYSTEINYLSERYLPROLYLGLYCYLISOLEUCYLTRYPTOPHANYL GLUTAMINYLLEUCYLASPARTYLCYSTEINE;
PHENYLALANYLASPARAGINYLLEUCYLPROLYLPROLYLVALYLVALYLALANYLLYSYL GLUTAMYLISOLEUCYLVALYLALANYLSERYLCYSTEINYLASPARTYLLYSYLCYSTEINYL GLUTAMINYLLEUCINE;
RECOMBINANT DNA;
RIBONUCLEASE H;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
THREONYLASPARTYLISOLEUCYLGLUTAMINYLTHREONYLLYSYLGLUTAMYLLEUCYL GLUTAMINYLLYSYLGLUTAMINYLISOLEUCYLTHREONYLLYSYLISOLEUCYLGLUTAMINYL ASPARAGINYLPHENYLALANYLARGINYLVALINE;
THREONYLHISTIDYLLEUCYLGLUTAMYLGLYCYLLYSYLVALYLISOLEUCYLLEUCYL VALYLALANYLVALYLHISTIDYLVALYLALANYLSERYLGLYCYLTYROSYLISOLEUCYLGLUTAMIC ACID;
TYROSYLTYROSYLARGINYLASPARTYLSERYLARGINYLASPARAGINYL PROLYLLEUCYLTRYPTOPHANYLLYSYLGLYCYLPROLYLALANYLLYSYLLEUCYLLEUCYL TRYPTOPHANYLLYSYLGLYCINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALYLARGINYLALANYLALANYLCYSTEINYLTRYPTOPHANYLTRYPTOPHANYLALANYL GLYCYLISOLEUCYLLYSYLGLUTAMINYLGLUTAMYLPHENYLALANYLGLYCYLISOLEUCYLPROLYL TYROSYLASPARAGINYLPROLINE;
VALYLGLUTAMINYLMETHIONYLALANYLVALYLPHENYLALANYLISOLEUCYL HISTIDYLASPARAGINYLPHENYLALANYLLYSYLARGINYLLYSYLGLYCYLGLYCYLISOLEUCYL GLYCYLGLYCYLTYROSYLSERINE;
AMINO ACID SEQUENCE;
ARTICLE;
CONFORMATIONAL TRANSITION;
CONTROLLED STUDY;
DRUG BINDING;
DRUG INHIBITION;
DRUG SCREENING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MOLECULAR DOCKING;
MOLECULAR MODEL;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
STEREOSPECIFICITY;
AMINO ACID SEQUENCE;
DNA;
HIV INTEGRASE;
HIV-1;
HIV-1 REVERSE TRANSCRIPTASE;
MODELS, MOLECULAR;
MOLECULAR SEQUENCE DATA;
PEPTIDE FRAGMENTS;
PEPTIDE LIBRARY;
PROTEIN CONFORMATION;
RECOMBINANT PROTEINS;
REVERSE TRANSCRIPTASE INHIBITORS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 33846841959
PISSN: 00039861
EISSN: 10960384
Source Type: Journal
DOI: 10.1016/j.abb.2006.12.007 Document Type: Article |
Times cited : (15)
|
References (44)
|